US Patent

US10792271 — Topical formulations of chloroprocaine and methods of using same

Method of Use · Assigned to Sintetica SA · Expires 2038-09-15 · 12y remaining

Vulnerability score 70/100 Vulnerable — likely target for IPR or design-around

What this patent protects

This patent protects topical formulations of chloroprocaine and methods for using them, particularly for ophthalmic procedures or injuries.

USPTO Abstract

Topical dosages and formulations of chloroprocaine and pharmaceutically acceptable salts thereof are provided that are efficacious, chemically stable and physiologically balanced for safety and efficacy, particularly during ophthalmic procedures or in response to ophthalmic abrasions or trauma.

Drugs covered by this patent

chloroprocaine-hydrochloride (CHLOROPROCAINE HYDROCHLORIDE)

FDA Patent Use Codes

When a patent is method-of-use, FDA lists it once per applicable indication ("U-code"). Each U-code carves out a specific therapeutic use that generic filers must either license or design around.

Code	Description	Drug
`U-3457`	—	chloroprocaine-hydrochloride

Patent Metadata

Patent number: US10792271
Jurisdiction: US
Classification: Method of Use
Expires: 2038-09-15
Drug substance claim: No
Drug product claim: Yes
Assignee: Sintetica SA
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.